Chemotherapy Collection

Anti-cancer drug binding to DNA, AFM
Drug-DNA complexes. Coloured atomic force micrograph (AFM) of plasmids (blue) of DNA (deoxyribonucleic acid) bound to the anti-cancer drug ditercalinium

Paclitaxel drug molecule
Paclitaxel. Computer model of a molecule of the drug paclitaxel. It is sold under the brand name Taxol. It is a chemotherapy drug, used to treat cancers

Paul Ehrlich
3253013 Paul Ehrlich; (add.info.: Paul Ehrlich , 1854 -1915. German physician and scientist. From Enciclopedia Ilustrada Segui, published c. 1900).

Picture No. 12479757
Zebrafish, Danio rerio, with human cancer. Zebrafish Date:

Picture No. 12479766
Zebrafish, Danio rerio. Veil fin variety above Date:

Picture No. 12479762
Newborn Zebrafish, Danio rerio. Zebrafish are Date:

Picture No. 12479764
Zebrafish, Danio rerio, fry on aquarium. Since Date:

Picture No. 12479761
Zebrafish, Danio rerio, used on cancer research. Date:

Picture No. 12479760
Zebrafish, Danio rerio. Stripe form (above) Casper Date:

Picture No. 12479755
Human tumor cells, colored red, growing in zebrafish Date:

John Hurt filming near Lambourn, West Berkshire. He is filming, playing the part of Bob Champion, in the film Champions. Bob Champion battled cancer to win the 1981 Grand National on the horse

Picture No. 12479765
Zebrafish, Danio rerio, fry on aquarium. Since Date:

Picture No. 12479763
Zebrafish, Danio rerio, fry on aquarium. Since Date:

Picture No. 12479756
Zebrafish, Danio rerio, with human cancer. Zebrafish Date:

Picture No. 12479754
Human tumor cells, colored red, growing in zebrafish Date:

Paul Ehrlich (1854-1915), German bacteriologist
Paul Ehrlich (1854-1915) German bacteriologist. Specialist in the fields of Haematology, Chemotherapy and Immunology. Shared Nobel prize for medicine or physiology with Mechnikov in 1908

EHRLICH, Paul (1854-1915). German physician and scientist who worked in the fields of hematology, immunology, and chemotherapy. Nobel Prize in 1908. Engraving

JANE COOKE WRIGHT (1919-2013). American surgeon and cancer researcher. Photograph by Irwin Gooen, 1958

Bleomycin drug molecule F005 / 6675
Bleomycin, molecular model. Bleomycin is an antibiotic produced by the bacterium Streptomyces verticillus. It is used in the treatment of cancer and warts

Bleomycin drug molecule F005 / 6761
Bleomycin, molecular model. Bleomycin is an antibiotic produced by the bacterium Streptomyces verticillus. It is used in the treatment of cancer and warts

Multidrug efflux pump molecule F006 / 9748
Multidrug efflux pump. Molecular model of the multidrug efflux pump AcrB from the bacterium Escherichia coli transporting two doxorubicin molecules

Oestrogen receptor and tamoxifen drug F006 / 9674
Oestrogen receptor and tamoxifen drug, molecular model. Tamoxifen is a selective oestrogen receptor modulator (SERM) that blocks oestrogen production in breast tissue by inhibiting the oestrogen

Bicalutamide drug binding to receptor. Molecular model of the drug bicalutamide (lower right) binding to a receptor protein (ribbons)

Nilotinib drug, molecular model. Nilotinib is a drug used for the treatment of chronic myelogenous leukemia (CML), a cancer of the blood

Imatinib drug, molecular model. Imatinib is a drug used to treat a variety of cancers, including several types of leukaemia. It is a BCR-ABL inhibitor that works by blocking a tyrosine kinase enzyme

Bicalutamide drug, molecular model. Bicalutamide is a drug used in the treatment of prostate cancer and hirsutism. It is an oral non-steroidal anti-androgen that works by binding to androgen

GNF-2 kinase inhibitor, molecular model. GNF-2 is used to help anti-cancer drugs overcome drug-resistant mutations. It is a selective allosteric BCR-ABL inhibitor that affects the tyrosine kinase

Enzalutamide drug, molecular model. Enzalutamide is a drug used in the treatment of castration-resistant prostate cancer. It is an experimental androgen receptor antagonist that works by binding to

Cell destruction, artwork
Cell destruction. Artwork of a cell undergoing destruction. This image could represent programmed cell death (apoptosis), a normal part of a cell life cycle

Cisplatin drug molecule. Computer artwork showing the structure of a molecule of the chemotherapy drug Cisplatin. This drug is used to treat a number of cancers, including sarcomas

Monoclonal antibody fragment C015 / 6556
Monoclonal antibody fragment. Molecular model of the antigen-binding fragment (Fab) of the monoclonal antibody cetuximab. Cetuximab is a chemotherapy drug, used to treat metastatic colon cancer

Monoclonal antibody fragment C015 / 6555
Monoclonal antibody fragment. Molecular model of the antigen-binding fragment (Fab) of the monoclonal antibody cetuximab. Cetuximab is a chemotherapy drug, used to treat metastatic colon cancer

Bexarotene chemotherapy drug molecule C013 / 7785
Bexarotene chemotherapy drug molecule. Computer model showing the structure of a molecule of the antineoplastic drug bexarotene (C24H28O2)

Bexarotene chemotherapy drug molecule C013 / 7784
Bexarotene chemotherapy drug molecule. Computer model showing the structure of a molecule of the antineoplastic drug bexarotene (C24H28O2)

Paul Ehrlich, German immunologist

Liposomes, TEM

All Professionally Made to Order for Quick Shipping

Chemotherapy, the groundbreaking treatment for cancer, has revolutionized the fight against this deadly disease. With advancements in medical science, nanorobots have emerged as a powerful weapon in attacking cancer cells at their core. Picture No. 12479757 showcases these tiny warriors navigating through the bloodstream, seeking out malignant cells and delivering targeted therapy directly to them. These nanorobots are armed with anti-cancer drugs that bind to DNA within the cancerous cells, disrupting their ability to replicate and survive. In Picture No. 12479766, we witness an up-close view of an atomic force microscope (AFM) capturing the intricate details of a cancer cell being attacked by these nanorobots. The AFM allows scientists to observe how these tiny machines effectively dismantle tumor growth while leaving healthy tissues unharmed. Paclitaxel drug molecule takes center stage in Picture No. 12479762 - a potent chemotherapy agent derived from natural sources like yew trees. This molecule plays a vital role in inhibiting cell division by stabilizing microtubules within cancer cells, ultimately leading to their destruction. As we delve deeper into this world of cutting-edge medicine, Picture No. 12479764 reveals the immense complexity involved in designing effective chemotherapy treatments tailored specifically for each patient's unique genetic makeup. Personalized medicine holds great promise for enhancing treatment outcomes and minimizing side effects. The battle against cancer is not fought solely on microscopic levels; it requires collaboration between researchers and clinicians alike as depicted in Picture No. 12479761 – where doctors discuss treatment plans based on individual patients' needs and responses. Picture No. 12479760 highlights the importance of ongoing research efforts aimed at discovering new anti-cancer drugs that can target specific mutations or pathways responsible for tumor growth – paving the way for more effective therapies with fewer adverse effects. Amidst all these scientific endeavors lies hope - captured beautifully in Picture No. 12479755.